Teva, despite delivering in 2024, startles investors with subdued 2025 guidance

29th January 2025 Uncategorised 0

Despite finishing strong in 2024, Teva’s cautious approach to the new year appears to have investors spooked. The company’s subdued guidance likely explains the performance of Teva’s stock, which plunged 13% on Wednesday.

More: Teva, despite delivering in 2024, startles investors with subdued 2025 guidance
Source: fierce